Clinical Trial Update: Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2) [Phase 2]

View source ↗

Summary

This update reports Phase 2 results from a platform trial assessing the efficacy and safety of anti-malarial agents in adults with uncomplicated Plasmodium falc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Plasmodium Falciparum Malaria

Drugs mentioned

• Anti-malarial agents platform study (Cohort B2)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Uncomplicated Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED | Results posted: 2026-03-13